Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
To investigate and compare safety, pharmacokinetics and pharmacodynamics of BIBR 1048 MS following oral administration of single rising doses from 50 mg to 350 mg in healthy male subjects of Japanese and Caucasian origin. This was the first administration of this substance to subjects of Japanese origin.
Epistemonikos ID: 7a101938bcce2c2cb22b734de1be2adb11dd769b
First added on: May 11, 2024